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The Effects of Cognitive Behavioral Therapy Are Not Systematically
Falling: A Revision of Johnsen and Friborg (2015)
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Vrije University Amsterdam and EMGO Institute for Health and
Care Research, Amsterdam, the Netherlands
In a meta-analysis, Johnsen and Friborg (2015) reported a significant negative relationship between
publication year and the effect sizes (ESs) of cognitive–behavioral therapy (CBT) for depressive
disorders, suggesting its effectiveness was falling. We identified a series of methodological and con-
ceptual caveats and consequently redid the meta-analysis. We used the same inclusion criteria, but only
included randomized controlled trials and searched for additional eligible trials. We computed both
within-group and between-group ESs for the CBT arm for the Beck Depression Inventory (BDI) and the
Hamilton Rating Scale for Depression (HRSD). We assessed risk of bias, sample size, type of control
group, and the study’s country of origin and conducted subgroup, single, and multiple meta-regression
analyses including publication year and other moderators. We identified 30 additional eligible trials.
Within-group ESs presented huge heterogeneity estimates (I2 around 90%). Year of publication was
significant in some single meta-regression analyses on the BDI, but not significant in others, in most
analyses on the HRSD, and in any of the analyses on between-group ESs. Multiple regression models
indicated that either year was not significantly related or that both year and country were significantly
related to outcomes, with a temporal trend present solely in US studies. Year of publication does not
appear to be a reliable and independent moderator of the effectiveness of CBT for depression. The linear
“fall” reported by Johnsen and Friborg (2015) is most likely a spurious finding.
Keywords: cognitive behavioral therapy, depression, year of publication, meta-analysis, moderator
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A recent meta-analysis (Johnsen & Friborg, 2015) sent rip-
ples through the psychotherapy community, when its results
suggested that the effects of cognitive– behavioral therapy
(CBT) for depression seem to “have declined linearly and
steadily since its introduction” (p. 747). The authors conducted
a meta-analysis of trials of CBT for depression and used meta-
regression procedures to examine the relationship between the
year of publication and the effect sizes (ESs) in the CBT
intervention arm, examining outcomes on two widely used
depression scales: the Beck Depression Inventory (BDI) and the
Hamilton Rating Scale for Depression (HRSD). Their results
showed a significant decrease of the ESs over time for both the
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BDI (slope  0.029, p  .001), as well the HRSD
(slope  0.02, p  .01).
These results received a lot of attention in both scientific outlets
and the general media, with glum headlines announcing that CBT
may have “had its day as a treatment for depression” (Graham,
2015) or wistfully wondering why CBT “is falling out of favour”
(Burkeman, 2015). Unfortunately, most of the discussion has fo-
cused on the possible explanatory mechanisms behind these find-
ings, with a plethora of speculations ranging from procedural
issues related to the delivery of CBT and a possible reduction in
the integrity of delivery over time, to more general ones, such as
CBT following the temporal dynamics of the “placebo” effect.
Much less consideration has been given to the actual methodology
by which these results came about in Johnsen and Friborg (2015).
Nevertheless, we identified a number of questionable or unclear
aspects. First, the authors included both randomized and nonran-
domized trials. This issue is chief since randomization of partici-
pants to treatment groups serves to ensure that sources of bias are
equally distributed across the groups, with the only difference
among them being the intervention. Nonrandomized trials are
subject to a whole array of sources of bias to a degree we have no
way of appropriately gauging. Effects in these trials might be due
to many factors other than the intervention, such as the passage of
time, nonspecific factors like patients’ expectations (the “placebo”
effect), variables unbeknownst to the experimenter actually caus-
ing the changes, and so forth. Second, even if we just consider
randomized controlled trials (RCTs), the number of included trials
appeared to be relatively small (52) compared to other meta-
analyses of CBT for depression (Barth et al., 2013; Cuijpers et al.,
2013). Third, we noticed that the majority of heterogeneity values
(I2) reported by the authors were extremely high (around 90%),
suggesting that the variability among effect sizes was so large and
consequently the studies so inconsistent, that they would almost
seem to have very little in common. That raises serious doubts
about the combination of the included studies in the meta-analysis
(Ioannidis, Patsopoulos, & Evangelou, 2007). It is likely that at
least one of the sources for this high heterogeneity may be related
to the combination of different types of studies, like randomized
and nonrandomized. Fourth, the authors chose to focus on “com-
pleter” analyses instead of intent-to-treat (ITT) analyses. Yet land-
mark meta-epidemiological studies (Nüesch et al., 2009) have
demonstrated that not only do effect sizes from trials with patient
exclusions (i.e., restricted to completers) tend to benefit the inter-
vention more than trials without exclusions (ITT), but that the
differences in ESs between trials with and without exclusions also
seem to be more pronounced in meta-analyses with high hetero-
geneity among included trials, as seems to be the case of Johnsen
and Friborg (2015). Also, “completer” data are usually based on a
reduced number of participants and particularly exposed to the
attrition bias, given that drop-out might not be random and may be
related to the intervention. On the other hand, ITT analyses have
been criticized for being too conservative (Gupta, 2011), although
the available methods for conducting these analyses have evolved
over time. Furthermore, it is conceivable that “completer” analyses
may be more affected by changes over time in the effects for CBT
than ITT analyses. Johnsen and Friborg (2015) did not find dif-
ferences between studies reporting “completer” versus ITT data in
subgroup analyses, but this does not necessarily imply that using
one of these data sets is equivalent to the other. Fifth, the paper
relies on within-group effect sizes, which are problematic in that
they allow the integration of findings from studies with diverse
designs in a way that artificially inflates the estimation of the
effectiveness of a treatment by leveling differences due to meth-
odological quality and the larger context of the trial. Meta-analyses
relying on within-group ESs run the risk of crediting the interven-
tion with a lot of extraneous influences such as spontaneous
remission, regression to the mean, background variables that fa-
vored the intervention (e.g., participant expectations), and in-
creased heterogeneity due to different time spans between baseline
and posttest in included studies. Finally, the authors’ main analy-
ses considered publication year as a single moderator in single
meta-regression analysis. The authors also ran two-way interaction
analysis between year and other variables considered. But an
important test that was missing was conducting multiple analyses
using more than one of the potential moderators. Looking at each
moderator separately or in combinations of two is misleading as it
increases the number of multiple tests carried out on the same
dataset and thus the risk of Type I error and of seemingly signif-
icant findings that may be spurious.
Furthermore, at least two other important variables have also
been shown to change with the passing of time. One is trial quality,
with a recent meta-analysis (Chen et al., 2014) that examined
historical changes in the quality and quantity of psychotherapy
trials for depression revealing that trials improved over time on
most quality criteria considered. Another variable is sample size,
as earlier CBT trials had small samples and it has been demon-
strated for trials of psychotherapy in general that larger studies
yield smaller effects sizes (Barth et al., 2013; Cuijpers, van
Straten, Bohlmeijer, Hollon, & Andersson, 2010). In fact, meta-
analyses of CBT for depression also found evidence of this small
sample bias (Barth et al., 2013; Furukawa et al., 2014). Thus, the
apparent decline in the efficiency of CBT over time might be
masking the fact that trials were simply becoming larger and of
better quality (i.e., lower risk of bias). Johnsen and Friborg (2015)
did look at both these variables. For quality, they showed that it
was positively correlated with time, but did not find a significant
two-way interaction between it and year of publication in their
relationship with ESs. For sample size, they redid the analyses
excluding studies with samples under an arbitrarily defined cut-off
of 20, and showed that year remained a significant predictor of ES
in single meta-regression analysis. However, this definition of a
cut-off point is unfounded and certainly does not exclude the
potentially biasing effect of sample size. Similarly, given that at
least these three potential moderators (year, quality of the trial,
sample size) seem at least partly intercorrelated and each related to
depression outcomes, their inclusion in the same meta-regression
model would have been necessary. It could be that in this case, one
or all stop being predictive of outcome. Moreover, other moderator
variables could also be relevant, such as the type of control group
used, given that the effects of CBT have been shown to vary with
different control groups (Furukawa et al., 2014).
Our aim was to redo the meta-analysis conducted by Johnsen
and Friborg (2015), to clarify if year of publication remained a
significant moderator of the effects of CBT for depression after (a)
addressing potentially flawed or questionable methodological
choices; (b) adding missing RCTs that satisfied the original au-
thors’ criteria to the analyses; (c) examining between-group in






































































































327THE EFFECTS OF CBT ARE NOT SYSTEMATICALLY FALLING
control group; and (d) conducting multiple meta-regression anal-
yses including other moderators shown to be related to the effi-
ciency of CBT.
Method
Identification and Selection of Studies
Our starting point for study selection was represented by the
studies included by Johnsen and Friborg (2015). We used the same
inclusion criteria. Studies were included if (a) the implemented
intervention was “pure” CBT, (b) designed to treat depression, (c)
delivered by therapists trained in CBT, (d) in an individual face-
to-face format for (e) adults with (f) an unipolar depressive disor-
der of any kind as their primary psychiatric diagnosis, (g) with a
pretreatment BDI score over 13.5 and who (h) did not have acute
physical illnesses or bipolar or psychotic disorders, (i) with re-
ported outcomes on either the BDI or the HRSD. Similarly to
Johnsen and Friborg (2015), we included studies where partici-
pants received medication in addition to CBT, as well as studies on
inpatients. The only additional filter we added was that studies had
to be RCTs. We also included studies published in a language
other than English, because language restriction may easily result
in missing relevant studies (Higgins & Green, 2011, section
10.2.2.4).
However, we did not employ other methodological choices we
considered questionable. If a study contained more than one sub-
group of participants, Johnsen and Friborg (2015) included only
the one with the highest severity. There is no justification for this
choice, which could in fact be construed as data selection. There-
fore, if the study included more subgroups, we included them all
and pooled them at a study level. We also averaged results at study
level if the study included multiple comparisons, like different
variations of CBT (for instance, CBT with varying number of
sessions, or theoretically diverse CBT orientations). On the other
hand, for studies that included both CBT and a truncated form of
it (for instance, CBT without some components), or conversely
CBT and CBT with added elements (e.g., motivational interview-
ing), we only included the “pure” CBT condition, like Johnsen and
Friborg (2015). Similar to them, for studies with both a CBT and
a CBT plus medication arm, we only included the former.
After selecting the RCTs from the studies included by Johnsen
and Friborg (2015), we verified their inclusion criteria against a
database of 1,756 papers on the psychological treatment of depres-
sion, in order to identify potential missed studies. This database
has been described in detail elsewhere (Cuijpers, van Straten,
Warmerdam, & Andersson, 2008) and has been used in a series of
published meta-analyses (http://www.evidencebasedpsychotherapies
.org). It was developed through a comprehensive literature search
(from 1966 to January 2015) in which 16,365 abstracts from
PubMed (4,007 abstracts), PsycInfo (3,147 abstracts), Embase
(5,912 abstracts), and the Cochrane Central Register of Controlled
Trials (3,995 abstracts) were examined. This database is continu-
ously updated. These abstracts were identified by combining terms
indicative of psychological treatment and depression (both MeSH
terms and text words). Two researchers performed the selection of
additional studies independently from each other. Disagreements
were resolved through discussion.
Study Quality (Risk of Bias)
As a proxy for study quality, Johnsen and Friborg (2015) used
a scale for randomized trials called the Randomized Controlled
Trial Psychotherapy Quality Rating Scale (RCT-PQRS: Kocsis et
al., 2010). However, a recent analysis (Armijo-Olivo, Fuentes,
Ospina, Saltaji, & Hartling, 2013) of tools of evaluating method-
ological qualities of RCTs revealed inconsistencies between the
items in these tools and the Cochrane Collaboration Risk of Bias
(RoB; Higgins et al., 2011). For the RCT-PQRS, this analysis
revealed the scale included items not linked to any type of bias and
hence irrelevant for study quality (for example, a priori relevant
hypotheses that justify comparison group[s]), and also noted its
validity, particularly criterion validity, had not been assessed in
any way. For these reasons, as well as to increase the compara-
bility of our results with other meta-analyses of psychotherapy for
depression, we used four items from the RoB tool to assess trial
quality. These included adequate generation of the allocation se-
quence (selection bias); concealment of allocation to conditions
(selection bias); blinding of assessors to outcome (detection bias);
and dealing with incomplete outcome data (attrition bias). The fifth
item of the RoB tool, selective outcome reporting, was not in-
cluded as it is impossible to assess given the vast majority of
psychotherapy trials, especially older ones, have not been inde-
pendently registered.
Blinding of outcome assessors was rated as positive either if the
study described proper methods of ensuring blinding or if all
outcome measures were self-report scales, thus not requiring the
interaction with an assessor. Blinding of participants is impossible
to ensure in psychotherapy trials and was not rated. Dealing with
incomplete data was assessed as positive if ITT analyses were
conducted, meaning the authors employed a method of including
all randomized participants in the analysis.
So as to use study quality as a moderator in analyses, we also
computed a “risk of bias” score for each study, by giving one point
to each criterion for which a study could be rated as low RoB. In
this way, each included study had a score denoting low RoB,
ranging from 0 to 4, with higher values indicating low RoB on
more criteria. Two independent researchers rated risk of bias, and
disagreements were resolved through discussion. We also com-
puted Cohen’s Kappa interrater agreement for each of the four
items of the Cochrane Risk of Bias tool, prior to resolving dis-
agreements.
Potential Moderators
Given that one of our goals was to conduct multiple meta-
regression analyses looking at multiple predictors in the same
model, we chose to focus on variables that had already been
studied in the literature of psychotherapy for depression and shown
to be related to outcome. To maximize statistical power, we
included, as much as possible, variables that would be described in
most reports, including the older ones.
Some of the moderators considered by Johnsen and Friborg (2015)
(gender, baseline severity) have been shown to not be related to
outcomes in meta-analyses of CBT or psychotherapy for depression
(Cuijpers et al., 2014; Driessen, Cuijpers, Hollon, & Dekker, 2010).
Also, others were more appropriate for separate analyses (e.g., BDI
version, ITT vs. “completer” analyses), and we opted for this. Finally,






































































































328 CRISTEA ET AL.
taking medication, therapist competence), few reports contained data
or the information was often imprecise.
Therefore, as continuous variables, we included year of publi-
cation, number of subjects randomized in the CBT arm, and
number of CBT sessions. We also included the following categor-
ical moderators: recruitment type (clinical, defined as recruitment
from help-seeking general practice populations or outpatient sam-
ples vs. others); diagnosis (major depressive disorder diagnosed
according to a system such as the DSM or the Research Diagnostic
Criteria versus others); target group (adults vs. specific popula-
tions, such as elderly, postpartum depression, general medical
conditions); patient type (outpatient vs. inpatient); type of control
group (waitlist, care-as-usual or placebo vs. others); type of CBT
(use of Beck manual vs. others); country (U.S. vs. others).
Data Synthesis and Meta-Analysis
Outcome measures. Similar to Johnsen and Friborg (2015),
we used the BDI and HRSD as outcome measures. We also coded
the version of the BDI (BDI-I; Beck, Ward, Mendelson, Mock, &
Erbaugh, 1961 versus BDI-II; Beck, Steer, & Brown, 1996) and
HRSD (Hamilton, 1960) used in the study. If a study used multiple
versions of the HRSD, the one with 17 items was preferred.
Unlike Johnsen and Friborg (2015), we did not include treat-
ment recovery rates because (a) the rates were based on the BDI
and duplicated the information already obtained through the use of
the BDI while giving the false impression of a new outcome, and
(b) the pooling of absolute response rates is a problematic, insuf-
ficiently reliable, procedure in itself, because it typically results in
extremely high levels of heterogeneity. Hence it is usually dis-
couraged to pool such rates (Higgins & Green, 2011), sections
9.4.4. and 9.4.8).
We also differed in the choice regarding the preferential use of
“completer” versus ITT data, in the cases where both were avail-
able. We included both “completer” and ITT data for the studies
reporting both and conducted separate analysis: one in which we
chose ITT over “completer” outcome data (ITT preferred) and one
in which we did the opposite (“completer” preferred).
Effect size calculation. To calculate mean effect sizes, we
used the computer program Comprehensive Meta-Analysis/CMA
(version 3.3.070).
Johnsen and Friborg (2015) used an unusual combination of two
types of ES calculation. For studies not including a no-intervention
control group, they calculated a within ES for the CBT arm
(prepost within design in the original paper), computing a stan-
dardized mean difference (Cohen’s d). Importantly, they did this
for both nonrandomized trials, as well as for RCTs in which the
CBT arm was being compared to medication or another psycho-
therapy. However, for RCTs in which CBT was contrasted to no
treatment, a waitlist, or care-as-usual, they computed another type
of ES (controlled design), by calculating the difference between
pre- and posttest scores for the intervention and, respectively, the
control group, and then standardizing using the change scores.
There are two major problems with these distinct calculations.
First, for the main analysis the authors report all studies together,
effectively combining ESs calculated with the first method with
others calculated with the second (see Table 2 of their paper). Second,
for the prepost within design the authors combined RCTs with non-
RCTs, while for the other, the controlled design, they in fact included
only one part of RCTs. In this way, data from RCTs were broken
across two categories, making it impossible for the reader to assess the
relationship between year and ESs across such trials only.
Consequently, we opted for two types of analyses. In the first, we
computed prepost (within) ESs, using the procedures for the standard-
ized mean difference. Like Johnsen and Friborg (2015), we assumed
an r  .70 for pre to post correlation and we reported the indicator
corrected for small sample bias (Hedges & Olkin, 1985), Hedges’ g.
In the second, we calculated between groups ESs—the difference
between the CBT and the control group at posttest (standardized mean
difference), corrected for small sample bias as well (Hedges’ g).
Because we only included RCTs, we opted for the use of posttest
means only, a method not requiring the imputation of a prepost
correlation, which is usually absent in studies.
Assessment of heterogeneity. Like Johnsen and Friborg
(2015), and because we expected considerable heterogeneity among
studies, we used a random effects model (Borenstein, Hedges, Hig-
gins, & Rothstein, 2009) to pool mean effect sizes. We assessed
heterogeneity by calculating the I2 statistic, which indicates hetero-
geneity in percentages. A value of 0% indicates no observed hetero-
geneity, whereas larger values define increasing heterogeneity, with
25% as a threshold for low, 50% for moderate, and 75% or above for
high (Higgins, Thompson, Deeks, & Altman, 2003). We calculated
95% confidence intervals (CIs) around I2 (Ioannidis et al., 2007),
using the noncentral 2-based approach with the heterogi module for
STATA (Orsini, Bottai, Higgins, & Buchan, 2006).
Johnsen and Friborg (2015) did not report I2 for their main
analyses (the only I2 estimations given are in Table 4 of their
paper, which reports subgroup analyses). They also did not specify
a definition of outliers, but some studies clearly appeared to have
huge ESs and were referred to as outliers in their Results section.
We defined outliers as studies in which the 95% CI of the ES was
outside the 95% CI of the pooled studies, on both sides.
Meta-Regression Analyses
Testing whether moderators were related to ESs through meta-
regression was the main focus of the paper. We conducted both
single and multiple analyses. Meta-regression analyses were con-
ducted according to a random effects model using the Knapp-
Hartung method. More detailed single meta-regression analyses
were conducted with year as a moderator for: all included studies;
excluding studies on inpatients; excluding outliers; only on studies
with low RoB (more than 2 RoB criteria rated as low risk); and
separately for the BDI-I, BDI-II, and HRSD-17. These analyses
were done both favoring ITT over “completer” analyses and vice
versa. Two multiple regression models were used: one in which
only predictors shown to be significant in single meta-regression
analyses were included (parsimonious model) and another includ-
ing all predictors (full model).
Summary of Analyses
We present two separate sets of analyses. One includes only the
RCTs contained in Johnsen and Friborg (2015), and focuses on
within-group effects sizes, like in their main analyses. The added
element here, aside from correcting some small methodological
lapses, are multiple meta-regression analyses including more po-






































































































329THE EFFECTS OF CBT ARE NOT SYSTEMATICALLY FALLING
both, this first analysis gave priority to “completer” data over ITT
so as to enhance similarity to the original meta-analysis. The goal
is to give the reader a chance to ascertain how stable and specific
the moderating effect of year on depression outcomes is. The
second set is our version of a “gold standard” analysis, in which we
adjust all the methodological choices we consider questionable
and assess whether under these conditions we can still evidence a
systematic, linear decline in the efficacy of CBT. In this latter
analysis, we only retain the inclusion criteria of Johnsen and
Friborg (2015) and conduct a new meta-analysis that in our view
best improves the original.
Results
Selection and Inclusion of Studies
Johnsen and Friborg (2015) included a total of 52 RCTs. We
found four of them to not meet their own inclusion criteria: one
(McBride, Atkinson, Quilty, & Bagby, 2006) reported outcomes
for a subsample of an already included study (Quilty, McBride, &
Bagby, 2008); another (Forman, Herbert, Moitra, Yeomans, &
Geller, 2007) included participants selected to have a score on the
BDI or the Beck Anxiety Inventory over 9, so not necessarily
depressed; another (Brown, Evans, Miller, Burgess, & Mueller,
1997) included participants with alcoholism, not depression, as a
primary diagnosis and a BDI score over 10; and finally, another
(Liberman & Eckman, 1981) primarily targeted suicide attempters,
only some of whom were also depressed, and implemented pure
behavior therapy. Also, another included study (Kalapatapu et al.,
2014) was a secondary analysis (identified as such even in the title)
of another trial (Mohr et al., 2012), which was not included. We
therefore opted for the inclusion of the larger, more complete trial.
For two trials (Gallagher-Thompson & Steffen, 1994; McLean
& Hakstian, 1979), we found it impossible to calculate pre-to-post
ESs in the CBT arm for the BDI or HRSD, despite the fact these
were reported by Johnsen and Friborg (2015). Two studies (Hollon
et al., 1992; Quilty et al., 2008) had only been included in the
analysis for the BDI, even if they also reported data on the HRSD.
One study (Jacobson, Dobson, Fruzzetti, Schmaling, & Salusky,
1991) was wrongly listed by the authors as a controlled (not
randomized) trial, even though it was in fact an RCT.
Our database search identified 30 additional trials that satisfied
the criteria of Johnsen and Friborg (2015). Out of these, 25
reported data for the BDI and 23 for the HRSD. Thirteen studies
included outcome data for both the ITT and “completer” (12 for
the BDI and 9 for the HRSD). A full list of the included studies is
included in the references.
Characteristics and Risk of Bias of Included Studies
Selected characteristics of included studies are presented in
Appendix S1. Risk of bias in the included studies was consider-
able. The Kappa interrater agreement coefficients were 0.85 for
sequence generation, 0.88 for concealment of allocation, 0.82 for
blinding for outcome assessors, and 0.76 for dealing with incom-
plete data, showing good interrater agreement even prior to resolv-
ing disagreements. Estimates for each study are given in Appendix
S1. Only 17 of the 77 (22%) included studies had low RoB on 3
or 4 of the four criteria considered. Fifteen studies (19%) had high
or uncertain RoB on all the criteria considered.
Analysis Restricted to RCTs Included in Johnsen and
Friborg (2015)
We note that all analyses (main effects, simple and multiple
meta-regression) yielded almost identical results when all studies
identified as eligible (the studies in the original meta-analysis plus
the extra studies identified) were considered. A synthetic version
of these results is presented in Appendix S2.
Main Effects of CBT (Within-Group ESs)
“Completer” analyses were favored to maximize similarity with
the original meta-analysis. With the correction of some smaller
errors described above, we included 45 trials for the BDI resulting
in a Hedges’ g  1.64 (95% CI 1.46 to 1.82), and respectively 30
trials for the HRSD, with a g of 1.70 (95% CI 1.51 to 1.88), values
very similar to those of Johnsen and Friborg (2015), 1.58 for the
BDI, and 1.69 for the HRSD. Heterogeneity was extremely high
(84% for the BDI and 78% for the HRSD). Forest plots for both the
BDI and the HRSD are presented in the supplementary Figures S3
and S4.
Single Meta-Regression Analyses
Single meta-regression analyses with year of publication and the
other moderators, as well as multiple meta-regression, are pre-
sented in Table 1 and Table 2. They showed a significant relation-
ship between year of publication and outcome for the BDI in most
analyses, with the exception of low RoB studies and studies on the
BDI-II only. For the HRSD, the relationship was significant in half
of the analyses. Notably, when ITT data were favored, results were
similar for the BDI, but all indicated nonsignificant relationships
between year and outcomes for the HRSD. Country of publication
(U.S. vs. others) was also a significant moderator of outcome for
the analyses on the BDI, b1  0.61, p  .01.
Multiple Meta-Regression Analyses
In order to avoid collinearity, we calculated the correlations
among the predictors and found them all to be under 0.60. Multiple
meta-regression favoring “completers” showed that either year
was not significantly related to outcome (both the parsimonious
and full models for the HRSD; the full model for the BDI) or that
both year and country were significantly related to outcomes (the
parsimonious model for the BDI and for the BDI and HRSD taken
together). We examined the relationship between year and within-
group ESs separately for U.S. and non-U.S. studies. We focused
this analysis on the BDI because both year and country were
significant in the parsimonious model. Results are displayed in
Figure 1. For the 25 studies conducted in the U.S., there was a
significant negative relationship between year and outcomes
(b1  0.04; 95% CI: 0.07 to 0.01; p  .01) that was not
present for the 20 studies conducted outside of the U.S.
(b1  0.02, p  .18). Of note, the ESs from the earlier studies
were higher for studies conducted in the U.S. than for those






































































































330 CRISTEA ET AL.
to values closer to what non-U.S. studies engendered from the
beginning.
“New” Improved Meta-Analysis (Additional Studies
Added, Between-Group ESs, ITT Data Preferred Over
“Completer”)
Main effects of CBT (between-group ESs). For the BDI (see
Figure 2), 29 trials resulted in a Hedges’ g of 0.72 (95% CI 0.56
to 0.89), with moderate heterogeneity (I2  50%). For the HRSD
(see Figure 3), 19 trials aggregated in a Hedges’ g of 0.79 (95% CI
0.62 to 0.96), with moderate heterogeneity (I2  37%). Only 4
studies had both ITT and “completer” data.
Single meta-regression analyses. Single meta-regression
analyses (see Table 3) indicated no significant relationships be-
tween year of publication and outcomes, neither for the BDI nor
for the HRSD. However, the number of participants in the CBT
group and respectively recruitment from clinical samples were
significant predictors in all cases (BDI and HRSD averaged to-
gether, BDI only, HRSD only).
Multiple meta-regression analyses. Year of publication (see
Table 4) was not significant in any of the analyses. The analyses
combining the BDI and the HRSD, which were the most statisti-
cally powerful, found the number of subjects in the CBT arm to be
significantly negatively related to outcome in the parsimonious
model. This also was a significant predictor in the full model,
together with the study’s country of origin. Multiple regression on
the BDI and respectively the HRSD only found recruitment from
clinical samples as significantly and negatively associated to out-
come, but these analyses were based on a small number of trials,
and consequently the association might be spurious.
Discussion
The recent meta-analysis by Johnsen and Friborg (2015) sug-
gested that the efficiency of CBT for depression was declining
over time. We identified some potentially erroneous or unclear
methodological aspects in their paper. Building on previous re-
search showing that the quality and sample sizes of depression
trials had also changed over time, we wondered whether the
apparent decline in the effects of CBT over time might simply be
masking a well-documented phenomenon in outcome research:
trials simply become larger and better (i.e., less vulnerable to
biases) over time. Therefore, we undertook a revision of Johnsen
and Friborg (2015), with the goal of examining whether year still
remained a significant moderator of depression outcomes after (a)
addressing potential methodological flaws and disputable choices,
(b) including missing eligible trials, and (c) conducting more
extensive and reliable moderator analysis with more multiple
predictors.
We identified a series of errors and inconsistencies in the
selection of the studies. Four included studies did not satisfy the
authors’ own inclusion criteria, and one was a secondary analysis,
for which the authors did not include the primary trial. Of course,
meta-analyses are difficult to conduct, requiring a lot of effort and
resources, and small errors are inevitable and many times incon-
sequential. However, what appears more worrisome is the fact that
we identified thirty additional trials that were missed in Johnsen
and Friborg (2015), despite the fact they satisfied the authors’
inclusion criteria. This is more than half of the number of RCTs
(52) they did include and represents a problem with the potential
to alter the results. We used the same inclusion criteria so as to be
able to judge our findings against those of Johnsen and Friborg
(2015). However, some of these criteria might be considered as
unnecessarily strict. For instance, restricting studies to only indi-
vidual, face-to-face CBT is unsupported, given that other formats
of delivery (e.g., guided self-help) were shown to be as effective
(Barth et al., 2013; Cuijpers, Donker, van Straten, Li, & Ander-
sson, 2010). Also, the threshold of a pretreatment BDI score of
13.5 is completely arbitrary and unnecessary, particularly since
only studies on participants with depressive disorders were in-
Table 1
Single Meta-Regression Analyses With Year of Publication, Within-Group Effect sizes, Studies
Included in Johnsen & Friborg (2015) Only
Outcome measure
ITT preferred over “completer” “Completer” preferred over ITT
Coeff 95% CI pa Coeff 95% CI pa
BDI (I  II)
All studies .03 .05–.01 .0019 .04 .06–.02 .001
Inpatients excluded .03 .05–.01 .0026 .03 .06–.01 .001
Outliers excluded .02 .03–.00 .02 .02 .03–.01 .005
Inpatients & outliers excluded .02 .03–.00 .03 .02 .03–.01 .010
Only low RoB studies (2) .02 .01–.05 .19 .01 .05–.03 .50
BDI-I only .03 .07–.00 .03 .03 .07–.00 .04
BDI-II only .04 .10–.02 .19 .04 .10–.02 .14
HRSD (all versions)
All studies .02 .04–.01 .12 .03 .05–.00 .03
Inpatients excluded .02 .04–.01 .15 .02 .05–.00 .04
Outliers excluded .01 .01–.02 .37 .01 .03–.01 .26
Inpatients & outliers excluded .01 .01–.03 .24 .01 .03–.01 .39
Only low RoB studies (2) .05 .03–.13 .19 .01 .07–.09 .79
Only HRSD-17 .02 .05–.00 .10 .03 .05–.00 .02
Note. BDI  Beck Depression Inventory; HRSD  Hamilton Rating Scale for Depression; ITT  intent-to-
treat; RoB  risk of bias.
a The p levels in these columns indicate whether the relationship between year and effect size is significant in






































































































331THE EFFECTS OF CBT ARE NOT SYSTEMATICALLY FALLING
cluded. On the other hand, studies on inpatients have consistently
been shown to be a distinct category of trials, subject to a very
diverse set of constraints (e.g., participants are often not free to
leave the trial), so their combination with outpatient studies is
problematic.
We also made a number of methodological choices divergent
from Johnsen and Friborg (2015). We restricted our analysis to
RCTs, imposed no language restrictions, and calculated both
within (pre-to-post) group and between-group ESs. Moreover, all
within ESs were calculated with the same procedure, regardless of
whether the CBT arm came from a trial with an “inactive” or
active (e.g., other psychotherapy) control group. To aid compari-
son, we conducted two sets of analyses. One included only the
RCTs contained in Johnsen and Friborg (2015), and focused on
within-group effects sizes, like in their main analyses, while add-
ing the multiple meta-regression results with other predictors of
interest. The second is our version of the most improved analysis,
in which we modified all the methodological choices we consid-
ered questionable (i.e., additional studies included, between-group
ESs, and ITT data preferred over “completer”).
The result from our first analysis showed large prepost ESs for
CBT on both the BDI and the HRSD, with values very similar to
those reported by Johnsen and Friborg (2015). The most important
result was the extremely high level of heterogeneity, raising seri-
ous doubts about the reliability of the results. This was further
corroborated by the fact that a startling one fourth (in analysis
favoring “completers”) to one third (in analysis favoring ITT) of
the included studies were outliers (i.e., resulted in ESs with 95%
CI outside the 95% CI of the pooled ES). However, in our second,
improved meta-analysis, estimations of the effects of CBT com-
pared to a control group were, as expected, smaller, but accompa-
nied by only moderate heterogeneity, and with a small number of
Table 2
Single and Multiple Meta-Regression Analyses With All Moderators of Interest, Within-Group Effect Sizes, Studies Included in
Johnsen & Friborg (2015) Only (“Completer” Data Preferred Over ITT)
Outcome measure
Single Multiple: Parsimonious Multiple: Full model
Coeff 95% CI pa Coeff 95% CI pa Coeff 95% CI pa
HRSD  BDI-I  BDI-II
Year .03 .05–.01 .002 .03 .05–.01 .001 .02 .05–.01 .12
N .00 .02–.01 .58 .00 .01–.02 .47
RoB .13 .33–.06 .17 .11 .38–.17 .44
WL/CAU/PLA present .00 .46–.46 .99 .11 .66–.44 .68
Recr from clinical samples .08 .58–.42 .74 .03 .54–.60 .92
MDD vs other diagnosis .09 .38–.56 .69 .06 .60–.48 .82
Adults vs specific group .28 .21–.77 .26 .24 .26–.74 .33
Number of sessions .04 .01–.09 .12 .02 .10–.06 .58
Country (U.S. vs other) .56 .15–.98 .009 .39 .01–.79 .05 .59 .09–1.26 .09
Beck’s manual vs other .18 .34–.70 .49 .00 .64–.64 .99
Inpatients vs outpatients .58 2.06–.89 .43 .34 2.06–1.37 .69
BDI (I  II)
Year .03 .06–.01 .002 .03 .05–.01 .008 .03 .06–.00 .06
N .01 .02–.01 .27 .00 .01–.02 .80
RoB .14 .35–.08 .22 .05 .37–.27 .78
WL/CAU/PLA present .02 .53–.49 .93 .06 .67–.55 .85
Recr from clinical samples .13 .70–.44 .64 .16 .84–.54 .67
MDD vs other diagnosis .17 .36–.69 .53 .14 .48–.76 .65
Adults vs specific group .38 .17–.93 .17 .41 .16–.99 .15
Number of sessions .03 .02–.09 .20 .03 .12–.05 .43
Country (U.S. vs other) .61 .14–1.07 .01 .43 .00–.86 .05 .41 .36–1.18 .29
Beck’s manual vs other .35 .23–.93 .23 .31 .41–1.02 .39
Inpatients vs outpatients .59 2.21–1.02 .46 .27 2.13–1.58 .77
HRSD (all versions)
Year .03 .05–.00 .02 .01 .04–.01 .31 .01 .05–.03 .74
N .00 .01–.02 .71 .00 .02–.02 .85
RoB .10 .29–.09 .27 .03 .37–.31 .84
WL/CAU/PLA present .20 .71–.32 .44 .06 .65–.77 .86
Recr from clinical samples .09 .48–.66 .75 .13 .63–.88 .73
MDD vs other diagnosis .00 .56–.57 .99 .31 1.07–.44 .40
Adults vs specific group .48 .00–.97 .05 .38 .07–.82 .09 .42 .16–1.00 .15
Number of sessions .06 .02–.12 .01 .05 .01–.10 .09 .06 .06–.18 .29
Country (U.S. vs other) .36 .16–.89 .17 .16 .74–1.05 .72
Beck’s manual vs other .05 .73–.63 .88 .25 1.21–.70 .58
Inpatients vs outpatients .64 2.01–.73 .35 .18 2.05–1.70 .85
Note. ITT  intent-to-treat; BDI  Beck Depression Inventory; HRSD  Hamilton Rating Scale for Depression; N  number of participants randomized
in the CBT arm; RoB  risk of bias; WL  waitlist control; CAU  care-as-usual; PLA  placebo; Recr  recruitment; MDD  major depressive
disorder.
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Figure 1. Meta-regression analyses of the effects of year of publication on within-group effect sizes in analyses







































































































333THE EFFECTS OF CBT ARE NOT SYSTEMATICALLY FALLING
outliers, in line with previous meta-analyses of CBT compared to
a control group (Barth et al., 2013; Cuijpers et al., 2013). Given
that the collection of studies is similar to, in fact even narrower
than, that of previous meta-analyses, we conjecture that heteroge-
neity might have to do with the nature of prepost ESs. The idea that
one could be able to gauge the “pure” effect of CBT by combining
the CBT arms from different trials is in itself problematic.
Between-group ESs have the advantage of being calculated em-
Figure 2. Standardized between-group effect sizes of CBT on the Beck Depression Inventory in new
meta-analysis including all eligible trials.
Figure 3. Standardized between-group effect sizes of CBT on Hamilton Rating Scale for Depression in new






































































































334 CRISTEA ET AL.
bedded in the context of the trial in which participants were
randomized. As such, they also include the important assumption
that the intervention and the control group are not completely, if at
all, independent from each other. Within-group ESs, such as the
ones used by Johnsen and Friborg (2015), do not include this
non-independence assumption because they effectively detach the
intervention group from the context of the trial. Furthermore,
between-group effect sizes adjust for differences in target popula-
tions, interventions, and study design, because both the treatment
and control group have these same characteristics. Within-group
effect sizes, on the other hand, do not adjust for these differences
in any way. For example, length of treatment is highly important
because of natural recovery, which is considerable in depression.
In within-group effect sizes, length of treatment can be expected to
be an important predictor of the effect size, whereas this is not the
case in between-group effect sizes, because both treatment and
control group have the same length. Finally, by leveling differ-
ences due to methodological quality and the context of the trial,
meta-analyses of within-group ESs run the risk of artificially
inflating the apparent efficiency on an intervention, ascribing to it
a variety of extraneous influences.
Regarding the crux of our revision—the moderating value of
year of publication on depression outcomes—our results contra-
dict those of Johnsen and Friborg (2015). In the analyses similar to
their original, which used within-group ESs, year was a significant
moderator of outcome in single analyses for the BDI, with the
exception of studies reporting outcomes only on the BDI-II and of
studies with low risk of bias. Publication year was not, however, a
significant moderator when outcomes were measured on the
HRSD, with the exception of the analysis favoring “completer”
over ITT data. But even in this last case, excluding outliers or
considering only studies with low RoB rendered the relationship
non-significant. Single meta-regression also identified another
moderator: country where the trial was conducted. Most impor-
tantly, nonetheless, multiple meta-regression analyses on the BDI
and HRSD data collapsed together, as well as on the BDI taken
separately, evidenced one of two phenomena: either year stopped
being a significant moderator of outcome (full model) or both year
and country were significant (parsimonious model). When out-
comes were restricted to the HRSD, no predictor (year included)
remained significant in multiple meta-regression analyses.
In our subsequent improved meta-analysis, where we included
additional, eligible but missed, studies, favored ITT over “com-
pleter” data, and computed effects sizes in comparison to a control
group (between-group ESs), results were even more trenchant.
Year of publication was not a predictor of outcome in any of the
single or multiple meta-regression analyses, regardless of the out-
come measure. Indeed, the only significant predictors that consis-
tently emerged were the number of participants in the CBT arm
and recruitment from clinical samples, which were both negatively
related to outcome. However, given that we used the same inclu-
sion criteria as the original meta-analysis, we could calculate
between-group ESs for only 31 trials (the rest of the trials com-
pared CBT exclusively with another psychotherapy or pharmaco-
therapy). Since Johnsen and Friborg (2015) reported a similar
analysis on a larger number of trials, one might argue we had
smaller statistical power. However, we should note that level of
heterogeneity were just moderate for our analysis on between-
group ESs, a factor increasing statistical power.
As an exploratory examination, we attempted to disentangle the
link between year of publication and country for within-group ESs
by looking at the association between year and depression out-
comes separately, for studies published in the U.S. and for studies
published in other countries. Our results also indicated that al-
though the significant decrease of ESs over time was present in
studies conducted in the U.S., where earlier studies resulted in
much higher ESs and subsequently moved toward effect sizes
similar to the rest of the world, no significant decrease was found
in non-U.S. studies. We note that this finding might, too, be an
artifact, given the high levels of heterogeneity accompanying
analyses on within-group ESs. Interestingly but perhaps coinci-
dentally, a recent meta-analysis (Tuttle et al., 2015) of drug trials
for neuropathic pain has shown a similar geographical pattern in
the effectiveness of the placebo arm: ESs for this arm decreased
over time in trials conducted in the U.S. However, in that case,
study length and sample size were also significant moderators of
the within-group ESs, unlike in our analysis, although number of
participants in the CBT arm was negatively related to outcome for
between-group ESs.
In conclusion, we redid the meta-analysis conducted by Johnsen
and Friborg (2015) and uncovered a number of methodological
errors. Heterogeneity estimates were extremely high and a large
proportion of studies were outliers, effectively precluding the
realization of a meta-analysis (Ioannidis et al., 2007). Given that
our additional analyses of between-group ESs, as well as other
meta-analyses of CBT that included studies with larger and more
diverse samples did not come across such high heterogeneity, we
surmise the problem may lie with the combination of within-group
ESs. Most importantly, we found that the association of year of
publication with depression outcomes was unstable and fleeting,
present only under certain limited conditions, and completely
absent in others. Specifically, this relationship was almost com-
pletely absent in the within-group ESs analyses on the HRSD and
in all analyses that employed between-group ESs. Multiple meta-
Table 3
Single Meta-Regression Analyses With Year of Publication For
Between-Group ESs, All Controlled Studies (ITT Data Preferred
Over “Completer”)
Outcome measure Coeff 95% CI pa
BDI (I  II)
All studies .01 .03–.01 .22
Inpatients excluded .01 .03–.01 .23
Outliers excluded .01 .02–.01 .38
Inpatients & outliers excluded .01 .02–.01 .39
Only low RoB studies (2) .03 .02–.07 .25
BDI-I only .00 .03–.02 .59
BDI-II only .01 .09–.10 .85
HRSD (all versions)
All studiesb .00 .02–.02 .77
Inpatients excluded .00 .02–.02 .75
Only low RoB studies (2) .03 .03–.08 .28
Only HRSD-17 .00 .02–.02 .89
Note. BDI  Beck Depression Inventory; HRSD  Hamilton Rating
Scale for Depression; ITT  intent-to-treat; RoB  risk of bias.
a The p levels in this column indicate whether the relationship between year
and effect size is significant in meta-regression analyses (no results were






































































































335THE EFFECTS OF CBT ARE NOT SYSTEMATICALLY FALLING
regression analyses did not support the systematic decline in the
efficiency of CBT over time, with the exception of studies con-
ducted in the U.S. However, these results should not be construed
as implying that the effects of CBT have not declined from the
initial studies showing very large ESs. In the case of within-group
ESs, roughly a third of the studies were outliers and many of these
were early studies (Beck, Hollon, Young, Bedrosian, & Budenz,
1985; Carrington, 1979; McNamara & Horan, 1986; Rush, Beck,
Kovacs, & Hollon, 1977), so in a sense there was nowhere to go
but down. This is a not-uncommon phenomenon when testing a
new therapy, with the first studies showing large magnitude effects
(also called the “winner’s curse”). It is worth noting that some
more recent studies also found large ESs of CBT (Castonguay et
al., 2004; David, Szentagotai, Lupu, & Cosman, 2008; Quilty,
Dozois, Lobo, Ravindran, & Bagby, 2014).
Although it would be impossible to exclude with absolute cer-
tainty the possibility that year of publication might be systemati-
cally related to the effects of CBT for depression, for some
outcomes in some circumstances, this is not very probable. More
likely, the linear temporal trend (“fall”) reported by Johnsen and
Friborg (2015) is simply a spurious finding.
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